Cargando…
A novel microRNA miR-MTCO3P38 inhibits malignant progression via STAT3/PTTG1/MYC in hepatocellular carcinoma
Autores principales: | Guo, Deliang, Gu, Yang, Ma, Dong, Liu, Pengpeng, Chen, Baiyang, Liu, Zhisu, Wu, Ping, Liu, Quanyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9170612/ https://www.ncbi.nlm.nih.gov/pubmed/35685481 http://dx.doi.org/10.1016/j.gendis.2021.11.006 |
Ejemplares similares
-
Identification of 13 Key Genes Correlated With Progression and Prognosis in Hepatocellular Carcinoma by Weighted Gene Co-expression Network Analysis
por: Gu, Yang, et al.
Publicado: (2020) -
Lgr5-mediated p53 Repression through PDCD5 leads to doxorubicin resistance in Hepatocellular Carcinoma
por: Ma, Zhili, et al.
Publicado: (2019) -
DNASE1L3 arrests tumor angiogenesis by impairing the senescence-associated secretory phenotype in response to stress
por: Guo, Deliang, et al.
Publicado: (2021) -
Long noncoding RNA Linc01612 represses hepatocellular carcinoma progression by regulating miR-494/ATF3/p53 axis and promoting ubiquitination of YBX1
por: Liu, Pengpeng, et al.
Publicado: (2022) -
Mixed Neuroendocrine Carcinoma and Hepatocellular Carcinoma: A Case Report and Literature Review
por: Lan, Jianwei, et al.
Publicado: (2021)